Raymond James Financial Inc Novartis Ag Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Novartis Ag stock. As of the latest transaction made, Raymond James Financial Inc holds 896,364 shares of NVS stock, worth $104 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
896,364
Previous 907,812
1.26%
Holding current value
$104 Million
Previous $88.3 Million
13.12%
% of portfolio
0.04%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding NVS
# of Institutions
1,524Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.2 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$996 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$783 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...